Abstract:Cholesteatoma is an epidermal cyst with still unknown pathomechanism. The aim of the current study was to investigate molecular differences in the background of the hyperproliferative property and aggressive behavior typical of the cholesteatoma epithelium. The expression of three cytokeratin genes (KRT1, KRT10 and KRT19), the matrix metalloproteinase 9 gene (MMP9) and the tumor suppressor TP53 gene was measured by qRT-PCR in surgical samples of pediatric and adult cholesteatoma cases and their expression level was compared to that of normal skin samples from the retroauricular region of control individuals. Cholesteatoma samples were stratified according to the age of onset and recurrence for more detailed analysis. Our results showed identical expression pattern for KRT1 and KRT10, their expression was higher in pediatric cases than in adults, especially in pediatric recurrent samples. The expression level of KRT19 was inversely proportional to that of KRT1/KRT10, it was lower in the more invasive recurrent cases both in our pediatric and adult groups. As it was expected from the bone destructive behavior of cholesteatoma, a significantly elevated expression of MMP9 was measured in cholesteatoma samples, the highest level was found in adult recurrent cases. Low expression levels characterize the TP53 gene without significant differences in our samples. These findings demonstrate that cytokeratin expression distinguishes between pediatric/adult, nonrecurrent/recurrent cases, suggesting that distinct differentiation state and cell division potential characterize these cholesteatoma cases. KRT19 with a tumor suppressor potential might restrict the recurrence of cholesteatoma. The differences observed in gene expression profiles between cholesteatoma and control samples support the notion that cholesteatoma is a cystic lesion with tumor-like behavior because it is characterized by invasive, destructive growth and high tendency for recurrence.

Terminal differentiation of epithelial cells in middle ear cholesteatoma: investigation of patterns of expression of protein kinase C-delta and protein kinase C-eta.

A study of the protein tyrosine kinases pathway in human middle ear cholesteatoma

Enhanced Mitophagy in Cholesteatoma Epithelial Cells.

Cholesteatoma-associated fibroblasts modulate epithelial growth and differentiation through KGF/FGF7 secretion

[Role of Epithelial Cell Proliferation and Apoptosis in Human Middle Ear Cholesteatoma].

Activation of the EGFR/Akt/NF-κB/cyclinD1 survival signaling pathway in human cholesteatoma epithelium

The role of EGFR/PI3K/Akt/cyclinD1 signaling pathway in acquired middle ear cholesteatoma.

Expressions of EGFR and Phosphotyrosine in Human Middle Ear Cholesteatoma

Study on the Relationship Between the Proliferation and Apoptosis of Auditory Meatal Skin in Cholesteatoma

Analysis of KRT1, KRT10, KRT19, TP53 and MMP9 expression in pediatric and adult cholesteatoma

Transforming Growth Factor Beta and Wound Healing in Human Cholesteatoma

Study on the Correlation Between Tympanic Membrance Epidermal Stem Cells and the Middle Ear Cholesteatoma

The Expression and Significance of Heat Shock Protein 70 and Proliferating Cell Nuclear Antigen Protein in Human Middle Ear Cholesteatoma

Expression of the tumor suppressor gene PTEN in human middle ear cholesteatoma and its clinical significance

Ligand-Activated Peroxisome Proliferator-Activated Receptor Β/δ Facilitates Cell Proliferation in Human Cholesteatoma Keratinocytes

Effects of cholesteatoma debris extract on expression of p38MAPK signal transduction pathway in keratinocytes and their significance

Immunohistochemical Discrimination of Aggressivity Between the Cholesteatoma from Different Positions

Role of Autophagy in Acquired Cholesteatoma

Comparison of Tissue Factors in the Ontogenetic Aspects of Human Cholesteatoma

[Differential Expression of Toll-Like Receptors in Chronic Suppurative Otitis Media and Cholesteatoma].

44-plex cytokine profile of cholesteatoma